These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24839854)

  • 41. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. United States laws under review.
    Leahey M
    Med Device Technol; 2007; 18(3):44-5. PubMed ID: 17585722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical device warning letter pilot. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(44):11018-23. PubMed ID: 10557622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of medical devices in radiology: current standards and future opportunities.
    Smith JJ
    Radiology; 2001 Feb; 218(2):329-35. PubMed ID: 11161144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Auditing device clinical studies for US requirements.
    Donawa M
    Med Device Technol; 2007 Oct; 18(6):24-7. PubMed ID: 18078178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Watching over the medical device industry.
    Lenzer J
    BMJ; 2009 Jun; 338():b2321. PubMed ID: 19549649
    [No Abstract]   [Full Text] [Related]  

  • 50. Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure; direct final rule. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Apr; 75(62):16347-51. PubMed ID: 20383921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oversight overhaul: eliminating the premarket review of medical devices and implementing a provider-centered postmarket surveillance strategy.
    Scott B
    Food Drug Law J; 2011; 66(3):377-404, ii. PubMed ID: 24505854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutual Recognition of the Food and Drug Administration and European Community Member State Conformity Assessment Procedures; pharmaceutical GMP inspection reports, medical device quality system evaluation reports, and certain medical device premarket evaluation reports--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(69):17744-71. PubMed ID: 10177764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Medical Device Safety Act of 2009.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Apr; 360(15):1550-1. PubMed ID: 19297562
    [No Abstract]   [Full Text] [Related]  

  • 54. [Reference and Innovation: Research on the Construction of Medical Device Registrar System].
    Xu L; Lin S; Hu L; Yang Y; Wu Z; Huang J; Jiang H
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 May; 43(3):192-196. PubMed ID: 31184077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The medical device safety act of 2009: clarifying preemption.
    Turcott RG; Ashley EA
    Am J Ther; 2009; 16(6):471-4. PubMed ID: 19940607
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical devices; reclassification and codification of vitamin D test system--FDA. Final rule.
    Fed Regist; 1998 Jul; 63(145):40364-6. PubMed ID: 10181714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scope of the European Medical Device Directives.
    Donawa M
    Med Device Technol; 2008; 19(1):32, 34-5. PubMed ID: 18348437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Forces reshaping the performance and contribution of the U.S. medical device industry.
    Benson JS
    Food Drug Law J; 1996; 51(2):331-6. PubMed ID: 11822326
    [No Abstract]   [Full Text] [Related]  

  • 59. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical studies in Italy.
    Donawa M
    Med Device Technol; 2009; 20(7):18-21. PubMed ID: 20058650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.